Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Intercure Ltd. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 23 | 19 | −4 |
| Shares | 4.15M | 4.91M | +760.0K (+18.3%) |
| Value | $26.9M | $34.8M | +$7.93M (+29.5%) |
New holders (3)
Institutions that held Intercure Ltd. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Davy Global Fund Management Ltd | 21,441 | $152.0K | 0.02% |
| Royal Bank of Canada | 1,955 | $14.0K | 0.00% |
| JPMorgan Chase & Co | 737 | $5.00K | 0.00% |
Sold out (7)
Institutions that held Intercure Ltd. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Vident Investment Advisory, LLC | 58,140 | $375.0K |
| Goldman Sachs Group Inc | 47,378 | $307.0K |
| Virtu Financial LLC | 13,052 | $85.0K |
| Acadian Asset Management LLC | 2,837 | $18.0K |
| Advisor Group Holdings, Inc. | 500 | $3.00K |
| Toronto Dominion Bank | 231 | $1.00K |
| Bank of America Corp | 75 | $0 |